Food and Drug Administration

Center for Drug Evaluation and Research

 

Oncologic Drugs Advisory Committee Meeting

May 3-4, 2004

 

Briefing Material: May 3, 2004

PM session RSR-13

 

 

Table of Contents:

 

TAB 1: Clinical Review

 

TAB 2: Statistical Review

 

TAB 3: Clinical Pharmacology - Dosing Guidelines